Sudit S Mukhopadhyay Selected Research

Fanconi Anemia Complementation Group G Protein

1/2021

Re-definition and supporting evidence toward Fanconi Anemia as a mitochondrial disease: Prospects for new design in clinical management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sudit S Mukhopadhyay Research Topics

Disease

2	Fanconi Anemia (Fanconi's Anemia) 11/2020 - 06/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Iron Deficiencies 11/2020
1	Leukemia 06/2017

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 11/2020 - 06/2017
1	Fanconi Anemia Complementation Group G ProteinIBA 01/2021
1	coenzyme Q10 (CoQ10)IBA 01/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2021
1	Thioctic Acid (Lipoic Acid)IBA 01/2021
1	XenobioticsIBA 01/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2021
1	diepoxybutaneIBA 01/2021
1	SulfurIBA 11/2020
1	IronIBA 11/2020
1	FrataxinIBA 11/2020
1	Retinoic Acid Receptor alphaIBA 06/2017
1	CurcuminIBA 06/2017
1	Histones (Histone)IBA 06/2017
1	TransferasesIBA 06/2017
1	LigandsIBA 06/2017
1	GTP-Binding Proteins (G-Protein)IBA 06/2017
1	Phosphotransferases (Kinase)IBA 06/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2017

Therapy/Procedure

1	Transplantation 01/2021